Adlai Nortye Ltd.
ANL
$13.52
-$0.23-1.67%
Headlines
4/27/2024
-
Zolmax
4/25/2024
-
Zacks Investment Research
4/19/2024
-
The Fly
4/19/2024
-
The Fly
4/14/2024
-
Ticker Report
4/8/2024
-
Benzinga
4/8/2024
-
The Fly
4/8/2024
-
The Fly
4/5/2024
-
The Fly
4/5/2024
-
The Fly
4/5/2024
-
Simply Wall St
4/3/2024
-
Market News Video
3/29/2024
-
Globe Newswire
3/11/2024
-
The Fly
3/11/2024
-
The Fly
2/9/2024
-
The Fly
2/9/2024
-
The Fly
12/22/2023
-
Zolmax
12/22/2023
-
Zolmax
12/21/2023
-
Ticker Report
12/21/2023
-
Ticker Report
12/21/2023
-
Ticker Report
11/30/2023
-
The Fly
11/29/2023
-
The Fly
Filings
Friday, April 19, 2024
Sunday, December 31, 2023
Week of Jul 22 and 26 (est)
Price History
--
--
--
--
--
Corporate Info
848 230 7430
Ugland House
Grand Cayman, KY1-1104
Grand Cayman, KY1-1104
Business Description
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a...
more